Friday, March 27, 2009

Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax Tablets

Zydus Pharmaceuticals announced today that it has received final approval from the U.S.
FDA for its Abbreviated New Drug Application for Topiramate Tablets USP, 25mg, 50mg, 100mg, and 200mg. This product is available for immediate shipment.

the details can be read here.

No comments: